x
African Health Sciences

    Book Now

    • 256(41)530021
    • info@africanhealthsciences.org
    African Health Sciences
    • info@africanhealthsciences.org
    • Give Feedback
    • Home
    • About Us
    • Staff
    • Focus & Scope
    • For Authors
    • More Links
      • About The Journal
      • Latest Articles
      • Journal Archives
      • Our Events
      • Faq’s
    • Contact Us
    Logo

    Contact Info

    • P. O. Box 7072 Kampala, Uganda
    • +256(41)530021
    • info@africanhealthsciences.org
    • ISSN 1680-6905
    • <!--
    • -->

    03Sep2018

    Diagnostic utility of, and influence of tobacco usage and genetic predisposition on, immunoglobulin A, rheumatoid factor and anti-citrullinated peptide auto-antibodies in South African rheumatoid arthritis patients

    by admin,  0 Comments

    Pieter Meyer1, Mahmood Ally2, Bridget Hodkinson3, Ronald Anderson1, Mohammed Tikly3

    1. University of Pretoria, Immunology; NHLS, Immunology.
    2. University of Pretoria, Internal Medicine.
    3. University of the Witwatersrand, Rheumatology.

    Abstract

    Background: The immunoglobulin A isotypes of anti-cyclic citrullinated peptide antibodies (ACPA) and rheumatoid factor (RF) are associated with disease severity and progression in Caucasian rheumatoid arthritis (RA) patients, as well as with genetic predisposition and tobacco use.

    Objectives: To compare levels of ACPA-IgA and RF-IgA with those of ACPA-IgG and cRF in a cohort of black South African RA patients and healthy controls.To investigate the relationship between IGA autoantibodies and disease severity, genetic predisposition and tobacco use

    Methods: RF-IgA and ACPA-IgA were determined in a cohort of predominantly black South African RA patients (n=75) in relation to serodiagnostic and prognostic potential, as well as tobacco use and genetic predisposition. Healthy control subjects were included to determine sensitivity, specificity and predictive values.

    ACPA-IgG/IgA and RF-IgA were determined by enzyme immunoassay and hs-CRP and cRF by nephelometry. Cotinine levels were  determined by ELISA.

    Results: The frequencies of ACPA-IgA and RF-IgA were 31% and 88% respectively compared to 88% for both types of traditional autoantibody procedures. ACPA-IgA was significantly higher (p=0.007) in patients with short disease duration, while linear regression analysis revealed a positive relationship with baseline disease activity scores. Levels of ACPA-IgG and ACPA–IgA were significantly higher in tobacco users who carried the HLA shared epitope.

    Conclusion: Although lacking in serodiagnostic superiority over cRF and ACPA-IgG, inclusion of RF-IgA and ACPA-IgA in autoantibody panels may provide insights into disease pathogenesis, interactions between tobacco usage and HLA genotype in the production of potentially disease-triggering ACPA-IgA antibodies.

    Keywords: Tobacco usage, genetic predisposition, immunoglobulin A, anti-citrullinated peptide, South Africa, rheumatoid arthritis patients.

    DOI: https://dx.doi.org/10.4314/ahs.v18i2.14

    Cite as: Meyer P, Ally M, Hodkinson B, Anderson R, Tikly M. Diagnostic utility of, and influence of tobacco usage and genetic predisposition on, immunoglobulin A, rheumatoid factor and anti-citrullinated peptide auto-antibodies in South African rheumatoid arthritis patients. Afri Health Sci. 2018;18(2): 295-303. https://dx.doi.org/10.4314/ahs.v18i2.14

    Diagnostic utility of, and influence of tobacco usage and genetic predisposition on,  immunoglobulin A, rheumatoid factor and anti-citrullinated peptide auto-antibodies in South African rheumatoid arthritis patients.PDF

    Related posts:

    The association between periodontal disease and adverse pregnancy outcomes in Northern Tanzania: a ...

    Prevalence and associated factors of Plasmodium falciparum and soil transmitted helminth infections ...

    Multidrug-resistant pattern of food borne illness associated bacteria isolated from cockroaches in m...

    Recent Posts

    • Editor’s choice: Tackling infectious diseases, NCDs and sexual reproductivehealth issues as we enter our 24th year of remarkable growth
    • Preconception and contraceptive care for women living with HIV/AIDSattending antiretroviral treatment clinics in Lagos State, Nigeria
    • Effects of SNPs on TNF-α and IL-10 cytokine expression in TB and HIVpatients in the Capricorn district, Limpopo Province, South Africa
    • Prevalence of Schistosomiasis in a neglected community, South western Nigeria at two points in time, spaced three years apart
    • Review of Leishmaniasis in the Middle East and North Africa

    Recent Comments

    No comments to show.

    Archives

    • April 2024
    • May 2019
    • April 2019
    • September 2018
    • August 2018
    • January 2018
    • December 2017
    • November 2017
    • October 2017
    • September 2017

    Categories

    • 2001 Issues
    • 2002 Issues
    • 2003 Issues
    • 2004 Issues
    • 2005 Issues
    • 2006 Issues
    • 2007 Issues
    • 2008 Issues
    • 2009 Issues
    • 2010 Issues
    • 2011 Issues
    • 2012 Issues
    • 2013 Issues
    • 2014 Issues
    • 2015 Issues
    • 2016 Issues
    • 2017 Issues
    • 2018 Issues
    • 2019 Issues
    • 2024 Issues
    • Articles
    • December issue
    • December Release
    • June Issue
    • June Release
    • March Issue
    • March Issue
    • March Release
    • News
    • number / volume 2
    • number /volume 1
    • number /volume 1
    • number /volume 1 2008
    • number 1
    • number 1
    • number 1
    • number 1
    • number 1
    • number 1
    • number 1
    • number 2
    • number 2
    • number 2
    • number 2
    • number 2
    • number 2
    • number 2
    • number 2 special Issue
    • number 2 special Issue 2
    • number 3
    • number 3
    • number 3
    • number 3
    • number 3
    • number 3
    • number 3
    • number 4
    • number 4
    • number 4
    • number 4
    • number 4
    • number 4
    • number/ volume 3 2008
    • number/ volume 4 2008
    • number/volume 1
    • number/volume 1
    • number/volume 2
    • number/volume 2
    • number/volume 2 2008
    • number/volume 3
    • number/volume 3
    • number/volume 3
    • number/volume 4
    • number/volume1
    • September Issue
    • September Release
    • Special Edition
    • special Issue
    • Uncategorized
    • Vol. 24 No. 1 (2024)
    • volume 1
    • volume 1
    • volume 1
    • volume 2
    • volume 2
    • volume 2
    • volume 2
    • volume 2
    • volume 3
    • volume 3
    • volume 3
    • volume 3
    • volume 4
    • volume 4
    • volume 4
    • volume 4
    • volume1

    Categories

    • 2001 Issues
    • 2002 Issues
    • 2003 Issues
    • 2004 Issues
    • 2005 Issues
    • 2006 Issues
    • 2007 Issues
    • 2008 Issues
    • 2009 Issues
    • 2010 Issues
    • 2011 Issues
    • 2012 Issues
    • 2013 Issues
    • 2014 Issues
    • 2015 Issues
    • 2016 Issues
    • 2017 Issues
    • 2018 Issues
    • 2019 Issues
    • 2024 Issues
    • Articles
    • December issue
    • December Release
    • June Issue
    • June Release
    • March Issue
    • March Issue
    • March Release
    • News
    • number / volume 2
    • number /volume 1
    • number /volume 1
    • number /volume 1 2008
    • number 1
    • number 1
    • number 1
    • number 1
    • number 1
    • number 1
    • number 1
    • number 2
    • number 2
    • number 2
    • number 2
    • number 2
    • number 2
    • number 2
    • number 2 special Issue
    • number 2 special Issue 2
    • number 3
    • number 3
    • number 3
    • number 3
    • number 3
    • number 3
    • number 3
    • number 4
    • number 4
    • number 4
    • number 4
    • number 4
    • number 4
    • number/ volume 3 2008
    • number/ volume 4 2008
    • number/volume 1
    • number/volume 1
    • number/volume 2
    • number/volume 2
    • number/volume 2 2008
    • number/volume 3
    • number/volume 3
    • number/volume 3
    • number/volume 4
    • number/volume1
    • September Issue
    • September Release
    • Special Edition
    • special Issue
    • Uncategorized
    • Vol. 24 No. 1 (2024)
    • volume 1
    • volume 1
    • volume 1
    • volume 2
    • volume 2
    • volume 2
    • volume 2
    • volume 2
    • volume 3
    • volume 3
    • volume 3
    • volume 3
    • volume 4
    • volume 4
    • volume 4
    • volume 4
    • volume1

    Archives

    • April 2024
    • May 2019
    • April 2019
    • September 2018
    • August 2018
    • January 2018
    • December 2017
    • November 2017
    • October 2017
    • September 2017

    Tags

    Achives Latest News


    ISSN 1680-6905

    • P. O. Box 7072 ,Kampala, Uganda
    • Call Us: 256(41)530021
    • info@africanhealthsciences.org

    Latest Activities

    Usefull Link

    • About AHS
    • Services
    • Focus & Scope
    • Our Articles
    • Contact Us

    Subscribe

    For research updates from African Health Sciences, sign up now!

      African Health Sciences © All Right Reserved